Latest Coya Therapeutics News & Updates

See the latest news and media coverage for Coya Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Coya Therapeutics

Clinical-stage biotech developing Treg therapies

coyatherapeutics.com
Headquarters
Houston, United States
Founded year
2020
Company type
Private company
Number of employees
2–20

Latest news about Coya Therapeutics

Company announcements

  • Coya Therapeutics

    Coya Therapeutics announces biomarker study publication

    The study shows correlations between oxidative stress, inflammation, neuronal injury biomarkers and ALS progression. Findings support COYA 302's rationale.

  • Coya Therapeutics

    Coya Therapeutics announces biomarker study publication

    The study correlates ALS biomarkers with survival, supporting COYA 302's rationale. Published in Annals of Clinical and Translational Neurology.

  • Coya Therapeutics

    Coya Therapeutics announces board transition and appoints Mark H. Pavao

    Founder Howard Berman steps down as Executive Chairman. Mark H. Pavao joins as independent director with extensive biopharma experience.

  • Coya Therapeutics

    Coya Therapeutics announces publication on Treg dysfunction in FTD

    Study shows reduced Treg function and increased inflammation in FTD patients, supporting COYA 302 therapy. Published in Brain Communications.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Coya Therapeutics

Track Coya Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.